<--- Back to Details
First PageDocument Content
Endometrial cancer / Trastuzumab / Uterine serous carcinoma / Breast cancer / Ovarian cancer / Gynaecological cancer / Medicine / HER2/neu
Date: 2015-02-11 15:54:34
Endometrial cancer
Trastuzumab
Uterine serous carcinoma
Breast cancer
Ovarian cancer
Gynaecological cancer
Medicine
HER2/neu

PETER BAKER forefront “It’s a unique opportunity for our USC patients because we will soon be able to translate our discoveries into novel therapeutics that will improve patient outcomes.”

Add to Reading List

Source URL: www.yalecancercenter.org

Download Document from Source Website

File Size: 138,60 KB

Share Document on Facebook

Similar Documents